D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Genetics and Molecular Biology D-index 87 Citations 37,466 246 World Ranking 719 National Ranking 1
Medicine D-index 83 Citations 41,359 240 World Ranking 8169 National Ranking 19

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • DNA

Jeremy A. Squire mainly investigates Genetics, Cancer research, Cancer, Molecular biology and Gene. The Cancer research study combines topics in areas such as Prostate cancer, Stem cell, Tumor suppressor gene, Survival analysis and PTEN. Lung cancer, Adenocarcinoma, Oncology and Internal medicine is closely connected to EGFR Gene Amplification in his research, which is encompassed under the umbrella topic of Survival analysis.

He interconnects Fluorescence in situ hybridization, Haploinsufficiency and Pathology in the investigation of issues within PTEN. His study on Cancer also encompasses disciplines like

  • Bioinformatics and related Osteosarcoma,
  • Genome instability which connect with Cell biology. His Molecular biology research incorporates themes from Cell cycle checkpoint, Chromosomal translocation, Chromosomal rearrangement, Cell division and DNA.

His most cited work include:

  • Identification of human brain tumour initiating cells (5872 citations)
  • Identification of a Cancer Stem Cell in Human Brain Tumors (4129 citations)
  • Erlotinib in lung cancer - molecular and clinical predictors of outcome. (1679 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Genetics, Cancer research, Molecular biology, Pathology and Fluorescence in situ hybridization. His study in Genetics concentrates on Gene, Comparative genomic hybridization, Chromosome, Gene duplication and Chromosomal translocation. Jeremy A. Squire combines subjects such as Carcinogenesis, Cancer, Tumor suppressor gene, Prostate cancer and PTEN with his study of Cancer research.

His research in Prostate cancer intersects with topics in Erg, Prostate and Oncology. His research in Molecular biology tackles topics such as Chromosome instability which are related to areas like Genome instability. While the research belongs to areas of Fluorescence in situ hybridization, Jeremy A. Squire spends his time largely on the problem of Karyotype, intersecting his research to questions surrounding Cytogenetics, Aneuploidy, Breakpoint and Ploidy.

He most often published in these fields:

  • Genetics (40.97%)
  • Cancer research (40.13%)
  • Molecular biology (37.61%)

What were the highlights of his more recent work (between 2012-2021)?

  • PTEN (19.75%)
  • Cancer research (40.13%)
  • Prostate cancer (21.01%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in PTEN, Cancer research, Prostate cancer, Internal medicine and Oncology. Jeremy A. Squire has included themes like Immunohistochemistry, Cancer, Prostate, Tumor suppressor gene and Fluorescence in situ hybridization in his PTEN study. His Fluorescence in situ hybridization research is multidisciplinary, incorporating elements of Molecular biology, In situ hybridization and Tissue sections.

His Cancer research study combines topics from a wide range of disciplines, such as Immune checkpoint, Gene expression, DNA damage, Tumor microenvironment and Cancer cell. His work deals with themes such as In silico, Tensin, Genome instability and Pathology, which intersect with Prostate cancer. The various areas that Jeremy A. Squire examines in his Oncology study include Molecular pathology, Guideline, Biomarker, Tissue microarray and Cohort.

Between 2012 and 2021, his most popular works were:

  • Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology (898 citations)
  • Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity. (207 citations)
  • Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology (198 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • DNA

His primary areas of study are Prostate cancer, Cancer research, PTEN, Internal medicine and Oncology. The Prostate cancer study combines topics in areas such as Chromosome instability, Breast cancer, Prostate and Pathology. His studies link Fluorescence in situ hybridization with Pathology.

Jeremy A. Squire has researched Cancer research in several fields, including Gene expression profiling, Mdm2, Cell cycle, Regulation of gene expression and Drug resistance. His PTEN study integrates concerns from other disciplines, such as Fusion gene, Genome, Genome instability, In silico and Candidate gene. His Oncology study incorporates themes from Prostate-specific antigen, Guideline, Molecular pathology and Adenocarcinoma.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Identification of human brain tumour initiating cells

Sheila K. Singh;Cynthia Hawkins;Ian D. Clarke;Jeremy A. Squire.
Nature (2004)

8152 Citations

Identification of a Cancer Stem Cell in Human Brain Tumors

Sheila K. Singh;Ian D. Clarke;Mizuhiko Terasaki;Victoria E. Bonn.
Cancer Research (2003)

6191 Citations

Erlotinib in lung cancer - molecular and clinical predictors of outcome.

Ming Sound Tsao;Akira Sakurada;Jean Claude Cutz;Jean Claude Cutz;Chang Qi Zhu;Chang Qi Zhu.
The New England Journal of Medicine (2005)

2212 Citations

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

Neal I. Lindeman;Philip T. Cagle;Mary Beth Beasley;Dhananjay Arun Chitale.
Journal of Thoracic Oncology (2013)

1400 Citations

Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens.

Steven M. Pollard;Koichi Yoshikawa;Ian D. Clarke;Davide Danovi.
Cell Stem Cell (2009)

936 Citations

Role of KRAS and EGFR As Biomarkers of Response to Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21

Chang Qi Zhu;Gilda Da Cunha Santos;Keyue Ding;Akira Sakurada.
Journal of Clinical Oncology (2008)

841 Citations

Mutations in SUFU predispose to medulloblastoma

Michael D. Taylor;Ling Liu;Corey Raffel;Chi-chung Hui.
Nature Genetics (2002)

838 Citations

Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer.

D Lechardeur;K J Sohn;M Haardt;P B Joshi.
Gene Therapy (1999)

726 Citations

High-resolution mapping of mammalian genes by in situ hybridization to free chromatin.

H. H. Q. Heng;J. Squire;Lap-Chee Tsui.
Proceedings of the National Academy of Sciences of the United States of America (1992)

668 Citations

Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome.

Rosanna Weksberg;Ding Ren Shen;Yan Ling Fei;Qian Li Song.
Nature Genetics (1993)

498 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Jeremy A. Squire

Ming-Sound Tsao

Ming-Sound Tsao

Princess Margaret Cancer Centre

Publications: 139

Jeremy N. Rich

Jeremy N. Rich

University of Pittsburgh

Publications: 138

Robert G. Bristow

Robert G. Bristow

University of Manchester

Publications: 99

Justin D. Lathia

Justin D. Lathia

Cleveland Clinic Lerner College of Medicine

Publications: 87

Michael D. Taylor

Michael D. Taylor

University of Toronto

Publications: 85

Gerry Melino

Gerry Melino

University of Rome Tor Vergata

Publications: 83

Brenda L. Gallie

Brenda L. Gallie

University of Toronto

Publications: 76

Frances A. Shepherd

Frances A. Shepherd

Princess Margaret Cancer Centre

Publications: 75

Henry H.Q. Heng

Henry H.Q. Heng

Wayne State University

Publications: 73

Paul C. Boutros

Paul C. Boutros

University of California, Los Angeles

Publications: 70

Eleftherios P. Diamandis

Eleftherios P. Diamandis

Mount Sinai Hospital

Publications: 69

Mark A. Rubin

Mark A. Rubin

University of Bern

Publications: 65

Yuzhuo Wang

Yuzhuo Wang

University of British Columbia

Publications: 64

Stefan M. Pfister

Stefan M. Pfister

German Cancer Research Center

Publications: 63

Peter B. Dirks

Peter B. Dirks

University of Toronto

Publications: 62

Ichiro Nakano

Ichiro Nakano

University of Alabama at Birmingham

Publications: 58

Something went wrong. Please try again later.